PATENT CLAIM ANALYSIS

Application Number: 16087780
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "018200"]

Abstract:
The purpose of the present invention is to provide a peptide which has a neuroprotective action, a neuroprotective drug and neuropathic treatment containing said peptide, and a preventive or alleviative pharmaceutical composition. This is based on the finding that a peptide fragment isolated from proline-rich protein  4  (PRP 4 ) has a neuroprotective action.

Claim (Index 6):
A pharmaceutical composition for treating or preventing nerve damage comprising  claim 1 .

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.40476
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12219179', '14782912', '10902959', '13936853', '11991210']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7337913491793423
- 35 USC 102 Novelty (BERT): 0.4926655544812562
- Combined Prediction Score: 0.7096787697095337
- Mean Citation Score: 177.396456
- Max Citation Score: 179.92711
- Similarity Product: 115.13616719077584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test